A detailed history of Trexquant Investment LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Trexquant Investment LP holds 90,881 shares of AZN stock, worth $6.84 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
90,881
Holding current value
$6.84 Million
% of portfolio
0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $6.07 Million - $7.35 Million
90,881 New
90,881 $7.09 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $2.16 Million - $2.34 Million
30,849 New
30,849 $2.21 Million
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $598,288 - $718,229
10,096 New
10,096 $667,000
Q1 2021

May 13, 2021

SELL
$47.16 - $54.44 $3.17 Million - $3.66 Million
-67,204 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $3.26 Million - $3.9 Million
67,204 New
67,204 $3.36 Million
Q3 2020

Nov 06, 2020

SELL
$53.07 - $61.1 $1.76 Million - $2.02 Million
-33,119 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$43.1 - $55.31 $1.43 Million - $1.83 Million
33,119 New
33,119 $1.75 Million
Q3 2019

Nov 08, 2019

SELL
$40.12 - $45.47 $2.3 Million - $2.61 Million
-57,405 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$37.28 - $41.68 $2.17 Million - $2.42 Million
-58,077 Reduced 50.29%
57,405 $2.37 Million
Q1 2019

May 13, 2019

BUY
$35.49 - $43.02 $4.1 Million - $4.97 Million
115,482 New
115,482 $4.67 Million
Q4 2017

Feb 09, 2018

SELL
$32.09 - $34.78 $611,539 - $662,802
-19,057 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$28.96 - $34.0 $551,890 - $647,938
19,057
19,057 $646,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.